While there have been previous reports of using recombinant Ad5knob protein as a ligand molecule targeting CAR or as an inhibitor of adenovirus infection, this is the first report of using Ad5knob as a carrier for gene therapy by producing it in transfected cells and spreading it to surrounding cells [28,29]. The gene discussed is CXADR; the disease is adenoviridae infectious disease.